Lakefront Biotherapeutics reported EUR4.77M in Loan Capital for its fiscal quarter ending in June of 2026.





Loan Capital Change Date
argenx SE USD 36M 432K Jun/2026
AstraZeneca USD 26.01B 46M Jun/2026
Biogen USD 7.29B 1B Jun/2026
Genmab DKK 4.96B 28M Jun/2026
Gilead Sciences USD 20.86B 1.27B Mar/2026
GlaxoSmithKline GBP 13.95B 65M Jun/2026
GRIFOLS EUR 7.17B 1.91B Jun/2026
Hikma Pharmaceutical USD 1.49B 692M Dec/2025
Incyte USD 28.42M 994K Jun/2026
Merck EUR 11.21B 406M Jun/2026
Neurocrine Biosciences USD 169.5M 500K Mar/2023
Novartis USD 37.49B 42M Jun/2026
Roche Holding CHF 25.22B 2.21B Jun/2026
Sanofi EUR 14.65B 806M Jun/2026
UCB EUR 2.18B 634M Dec/2025
Vertex Pharmaceuticals USD 106.7M 4.7M Dec/2025